BioPharmSignal logoBioPharmSignal

Biotech News

Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference

Annexon, Inc. (ANNX)Annexon, Inc.Conference / presentation

BRISBANE, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love,

Open original release

Related news

ANNXAnnexon, Inc.2026-05-06 12:00 EST

Annexon to Present at the Bank of America Securities Health Care Conference 2026

HRMYHarmony Biosciences2026-03-31 12:05 EST

Harmony Biosciences to Participate in 25th Annual Needham Virtual Healthcare Conference

TEVATeva Pharmaceutical Industries2026-06-01 20:30 EST

Teva to Present at the Goldman Sachs Global Healthcare Conference

OGENOragenics2026-05-19 12:45 EST

Oragenics to Present at Sidoti’s Micro-Cap Virtual Investor Conference May 20-21

NERVMinerva Neuroscience2026-05-18 20:05 EST

Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference

ABOSAcumen Pharmaceuticals2026-07-07 11:30 EST

Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

ALKSAlkermes plc2026-06-03 20:05 EST

Alkermes to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

TEVATeva Pharmaceutical Industries2026-05-04 20:30 EST

Teva to Present at the BofA Securities Health Care Conference

NBIXNeurocrine Biosciences2026-05-05 13:00 EST

Neurocrine Biosciences to Present at the Bank of America Health Care Conference 2026

ANNXAnnexon, Inc.2026-05-27 12:00 EST

Annexon to Participate in Upcoming June Investor Conferences

View all latest news

Annexon, Inc.

Annexon is a neuroscience company focused on complement biology and autoimmune or neuroinflammatory disease. Its platform is built around modulating immune pathways in the nervous system and beyond.

Recent company news

ANNXAnnexon, Inc.2026-05-27 12:00 EST

Annexon to Participate in Upcoming June Investor Conferences

ANNXAnnexon, Inc.2026-05-07 20:01 EST

Annexon Reports First Quarter 2026 Financial Results, Portfolio Progress and Key Anticipated Milestones

ANNXAnnexon, Inc.2026-05-06 12:00 EST

Annexon to Present at the Bank of America Securities Health Care Conference 2026

ANNXAnnexon, Inc.2026-04-08 20:05 EST

Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference

ANNXAnnexon, Inc.2026-03-30 20:01 EST

Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones

Stock data

Close
5.13 USD
Market cap
861.81M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States